I
Intensity Therapeutics (INTS)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Intensity Therapeutics (INTS)
Intensity Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing an approach to treat solid tumor cancers. It leverages its DfuseRx technology platform to create proprietary drug formulations. Its product c... Read more
- USD0.49
- USD0.49
- USD0.46
- USD5.10
- -10.80%
- --
- 159.43k
- 1.37M
- 9M
- 0.29
- -89.60%
Stock News
48 minutes ago
Cramer calls weak ADP jobs data 'disturbing,' warns about stocks coming into earnings too hot
CNBC
54 minutes ago
Car buyers drove sales to a 4-year high to beat tariffs. Now sales are running out of gas.
MarketWatch
55 minutes ago
There's a new ETF focused on the AI revolution — and it's backed by a well-known tech analyst
Yahoo
57 minutes ago
Trump's tax bill would add $2.4 trillion to the debt, says Congress' budget watchdog
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
